IP Library Granted Patent US 10,624,993
Granted Patent B2
US 10,624,993 · App. 15/652,895 · Granted Apr 21, 2020

Compositions for regenerating defective or absent myocardium

Inventor: Robert G Matheny (Norcross, GA)
Assignee: CorMatrix Cardiovascular, INC.
A61L27/54A61K31/7088A61K31/726A61K35/22A61K35/34A61K35/37A61K35/38A61K35/407A61K35/50A61K35/545A61K38/1741A61K38/1825A61K38/1841A61K38/39A61K48/00A61L27/227A61L27/367A61L27/3629A61L27/3633A61L27/3683A61L27/3687A61L27/3834A61L27/3873A61L27/40A61L27/58A61K9/0019A61L2300/412A61L2300/414A61L2300/426A61L2300/45A61L2300/64A61L2400/06A61L2430/20A61L2430/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,624,993
App. No.
15/652,895
Granted
Apr 21, 2020
Kind
B2
Abstract

Compositions of the invention for regenerating defective or absent myocardium comprise an emulsified or injectable extracellular matrix composition. The composition may also include an extracellular matrix scaffold component of any formulation, and further include added cells, proteins, or other components to optimize the regenerative process and restore cardiac function.

Claims (3)

1. An injectable graft composition for myocardial tissue regeneration, comprising extracellular matrix (ECM) from mammalian heart tissue, said ECM subjected to a decellularization process, wherein endogenous cells and endogenous glycosaminoglycan (GAG) proteins are extracted from said ECM,

said ECM comprising exogenously added GAG proteins, said exogenously added GAG proteins being added to said ECM after said decellularization process is complete,

said exogenously added GAG proteins replacing said endogenous GAG proteins extracted from said ECM during said decellularization process, wherein bioactivity of said ECM in vivo is maintained.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2025
From: CORMATRIX CARDIOVASCULAR, INC.
To: CORVIVO CARDIOVASCULAR, INC.
Reel/Frame 070482/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2020
From: MATHENY, ROBERT G
To: CORMATRIX CARDIOVASCULAR INC
Reel/Frame 051527/0173 →
Continuity (3)
Continuation 13875043 · May 1, 2013
Division 11182551 · Jul 15, 2005
Related Publication 20170312394A1 · Nov 2, 2017
Cited By (1)
US 12,514,956